Tumor necrosis factor release by pulmonary alveolar macrophages

Area of Science:

• Immunology
• Cell Biology
• Oncology

Background:

• Tumor necrosis factor (TNF) is a monokine with known cytotoxic and tumor-necrosing activities.
• TNF may be involved in the host defense against malignancies.
• Pulmonary alveolar macrophages (AMs) are key immune cells in the lung.

Purpose of the Study:

• To investigate the capacity of pulmonary alveolar macrophages (AMs) to release tumor necrosis factor (TNF).
• To determine if AMs contribute to TNF-mediated immune responses in the lung.

Main Methods:

• A specific cytotoxicity assay was employed to detect TNF.
• Actinomycin-D-pretreated WEHI 164 murine sarcoma cells served as targets.
• Cytotoxicity mediated by AMs was compared to that of autologous blood monocytes (BMs).

Main Results:

• Pulmonary alveolar macrophages (AMs) demonstrated cytotoxicity levels comparable to blood monocytes (BMs).
• The observed cytotoxicity was attributed to a soluble factor released by effector cells.
• Cytotoxicity was completely abrogated by the addition of anti-TNF antibodies, confirming TNF involvement.

Conclusions:

• Pulmonary alveolar macrophages (AMs) are capable of releasing tumor necrosis factor (TNF).
• TNF production by AMs indicates a potential role in the pathogenesis of nonmalignant lung disorders.
• This suggests TNF's involvement not only in anti-tumor defense but also in inflammatory lung conditions.